Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “metformin”

8 pharma patents match "metformin" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 8
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 8 pharmaceutical patents matching "metformin" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

8 results for “metformin” · 30,257 patents in full index Clear search

  1. US 11197844

    Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancer

    The Regents of the University of California · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted
  2. US 10813909

    Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancer

    The Regents of the University of California · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  3. US 10668021

    Metformin hydrochloride osmotic pump tablet and preparation method therefor

    ELITE PHARMA TECHNOLOGY (SHANGHAI) CO., LTD. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  4. US 10363244

    Compositions comprising metformin and a glucokinase activator

    VTV THERAPEUTICS LLC · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted
  5. US 10064846

    Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

    VTV THERAPEUTICS LLC · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  6. US 9855251

    Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

    VTV THERAPEUTICS LLC · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  7. US 9359313

    Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

    VTV THERAPEUTICS LLC · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted
  8. US 8900638

    Solid preparation comprising alogliptin and metformin hydrochloride

    Takeda Pharmaceutical Company Limited · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted